Spinorio is an upcoming platform that unifies quantum‑native software, cloud infrastructure, and domain‑specific algorithms into a single environment for building and running hybrid gate‑based and annealing quantum applications.
Funding
Funding not disclosed
Founders
Product
Problem
Developing quantum applications is hindered by the complexity of hybrid gate‑based and annealing hardware, fragmented toolchains, and a lack of integrated platforms that guide users from algorithm design to execution. This limits researchers and organizations from efficiently exploiting quantum computing for optimization, chemistry, finance, and other domains.
Solution
Spinorio is a forthcoming platform that unifies quantum‑native software, cloud infrastructure, and domain‑specific algorithms into a single environment for building and running quantum applications. It supports hybrid gate‑based and annealing processors, enabling users to develop solutions for peptide therapeutic design, portfolio and scheduling optimization, protein folding, and financial modeling. The platform provides ready‑to‑use algorithm implementations such as QAOA and quantum amplitude estimation, along with tools to translate problem definitions into quantum circuits and execute them on target hardware. By offering an end‑to‑end workflow—from concept and data preparation through simulation, execution, and result analysis—Spinorio aims to lower the barrier to entry for quantum development across multiple industries.
Target Audience
Primary users are researchers, developers, and organizations in healthcare, finance, and industrial sectors seeking to apply quantum computing to optimization, chemistry, and machine‑learning problems.
Features
- Integrated development environment that abstracts hybrid gate‑based and annealing quantum hardware
- Library of domain‑focused algorithms (e.g., QAOA for optimization, quantum amplitude estimation for derivative pricing)
- Cloud‑based execution layer with support for simulation and remote access to quantum processors
- End‑to‑end workflow tools for problem formulation, circuit generation, and result visualization
- Domain templates for peptide therapeutics, protein folding, portfolio optimization, scheduling, and risk analysis
- Planned mid‑2026 release with early‑access program for selected partners and researchers